Changes in number of shares and votes in H+H International A/S
News Provided by GlobeNewswire2018-06-28
8 Views
Company announcement No. 364, 2018
Attachment
© 2018 GlobeNewswire, Inc. All Rights Reserved.
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
FSD Pharma (Nasdaq: HUGE) Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
